Novel nanomedicine inhibits progression of pancreatic cancer in mice

(American Friends of Tel Aviv University) A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene -- a gene that promotes the development of cancer -- and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival. The study may serve as a basis for the development of an effective cocktail of drugs for this deadly disease and other cancers.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news